MichaelA.KeatingMD

PubMed

• 1 citations
  Using a serosal trough for fashioning a continent catheterizable stoma: technique and outcomes
  Nima Baradaran, Andrew A. Stec, Angela D. Gupta, Michael A. Keating, John P. Gearhart> ;BJU International. 2013 May 1
• 18 citations
  Ventral phalloplasty
  Jorge Caso, Michael Keating, Alejandro Miranda-Sousa and, Rafael Carrion> ;Asian Journal of Andrology. 2007 Dec 28
• 73 citations
  ORIGINAL RESEARCH—SURGERY: Concomitant Ventral Phalloplasty During Penile Implant Surgery: A Novel Procedure That Optimizes Patient Satisfaction and Their Perception o...
  Alejandro J. Miranda-Sousa, Michael Keating, Sergio G. Moreira, Mark Baker, Rafael Carrion> ;The Journal of Sexual Medicine. 2007 Sep 1
• 12 citations
  Role of periureteral injections in children with vesicoureteral reflux.
  Michael Keating> ;Current Opinion in Urology. 2005 Nov 1
• Significance of angiogenin plasma concentrations in patients with acute myeloid leukaemia and advanced myelodysplastic syndrome.
  Verstovsek S, Kantarjian H, Aguayo A, Manshouri T, Freireich E, Keating M, Estey E, Albitar M> ;Br. J. Haematol.. 2001-08-01
• Plasma hepatocyte growth factor is a prognostic factor in patients with acute myeloid leukemia but not in patients with myelodysplastic syndrome.
  Verstovsek S, Kantarjian H, Estey E, Aguayo A, Giles FJ, Manshouri T, Koller C, Estrov Z, Freireich E, Keating M, Albitar M> ;Leukemia. 2001-08-01
• The use of a bioactive skin substitute decreases length of stay for pediatric burn patients.
  Lukish JR, Eichelberger MR, Newman KD, Pao M, Nobuhara K, Keating M, Golonka N, Pratsch G, Misra V, Valladares E, Johnson P, Gilbert JC, Powell DM, Hartman GE> ;J. Pediatr. Surg.. 2001-08-01
• High expression of the receptor tyrosine kinase Tie-1 in acute myeloid leukemia and myelodysplastic syndrome.
  Verstovsek S, Estey E, Manshouri T, Keating M, Kantarjian H, Giles FJ, Albitar M> ;Leuk. Lymphoma. 2001-07-01
• High-dose liposomal daunorubicin and high-dose cytarabine combination in patients with refractory or relapsed acute myelogenous leukemia.
  Cortes J, Estey E, O'Brien S, Giles F, Shen Y, Koller C, Beran M, Thomas D, Keating M, Kantarjian H> ;Cancer. 2001-07-01
• CD38 expression as an important prognostic factor in B-cell chronic lymphocytic leukemia.
  Ibrahim S, Keating M, Do KA, O'Brien S, Huh YO, Jilani I, Lerner S, Kantarjian HM, Albitar M> ;Blood. 2001-07-01
• Highly reproducible detection and semi-quantification of telomerase activity.
  Verstovsek S, Manshouri T, Kantarjian H, Giles FJ, Keating M, Estey E, Albitar M> ;BioTechniques. 2001-05-01
• Results of therapy with interferon alpha and cyclic combination chemotherapy in patients with philadelphia chromosome positive chronic myelogenous leukemia in early ch...
  Giles FJ, Kantarjian H, O'Brien S, Rios MB, Cortes J, Beran M, Koller C, Keating M, Talpaz M> ;Leuk. Lymphoma. 2001-04-01
• Clinical relevance of Flt1 and Tie1 angiogenesis receptors expression in B-cell chronic lymphocytic leukemia (CLL).
  Aguayo A, Manshouri T, O'Brien S, Keating M, Beran M, Koller C, Kantarjian H, Rogers A, Albitar M> ;Leuk. Res.. 2001-04-01
• Results of the fludarabine and cyclophosphamide combination regimen in chronic lymphocytic leukemia.
  O'Brien SM, Kantarjian HM, Cortes J, Beran M, Koller CA, Giles FJ, Lerner S, Keating M> ;J. Clin. Oncol.. 2001-03-01
• Loss of heterozygosity on chromosome 5 in adults with acute lymphoblastic leukemia.
  Faderl S, Gidel C, Kantarjian HM, Manshouri T, Keating M, Albitar M> ;Leuk. Res.. 2001-01-01
• High-dose rituximab therapy in chronic lymphocytic leukemia.
  Keating M, O'Brien S> ;Semin. Oncol.. 2000-12-01
• 11q23 abnormalities in patients with acute myelogenous leukemia and myelodysplastic syndrome as detected by molecular and cytogenetic analyses.
  Ibrahim S, Estey EH, Pierce S, Glassman A, Keating M, O'Brien S, Kantarjian HM, Albitar M> ;Am. J. Clin. Pathol.. 2000-11-01
• Angiogenesis in acute and chronic leukemias and myelodysplastic syndromes.
  Aguayo A, Kantarjian H, Manshouri T, Gidel C, Estey E, Thomas D, Koller C, Estrov Z, O'Brien S, Keating M, Freireich E, Albitar M> ;Blood. 2000-09-15
• 59 citations
  LEYDIG CELL TUMORS AND TUMORS ASSOCIATED WITH CONGENITAL ADRENAL HYPERPLASIA
  Mark A. Rich, Michael A. Keating> ;The Urologic Clinics of North America. 2000 Aug 1
• Clinical relevance of intracellular vascular endothelial growth factor levels in B-cell chronic lymphocytic leukemia.
  Aguayo A, O'Brien S, Keating M, Manshouri T, Gidel C, Barlogie B, Beran M, Koller C, Kantarjian H, Albitar M> ;Blood. 2000-07-15
• Differences between refractory anemia with excess blasts in transformation and acute myeloid leukemia.
  Albitar M, Beran M, O'Brien S, Kantarjian H, Frieriech E, Keating M, Estey E> ;Blood. 2000-07-01
• Variations in the low levels of cyclin D1/BCL1 have prognostic value in chronic lymphocytic leukemia.
  Ravandi-Kashani F, O'Brien S, Manshouri T, Lerner S, Sim S, Dodd K, Kantarjian H, Freireich E, Keating M, Albitar M> ;Leuk. Res.. 2000-06-01
• Deletions in the 13q14 locus in adult lymphoblastic leukemia: rate of incidence and relevance.
  Chung CY, Kantarjian H, Haidar M, Starostik P, Manshouri T, Gidel C, Freireich E, Keating M, Albitar M> ;Cancer. 2000-03-15
• ATM gene deletion in patients with adult acute lymphoblastic leukemia.
  Haidar MA, Kantarjian H, Manshouri T, Chang CY, O'Brien S, Freireich E, Keating M, Albitar M> ;Cancer. 2000-03-01
• Cyclophosphamide, ara-C and topotecan (CAT) for patients with refractory or relapsed acute leukemia.
  Cortes J, Estey E, Beran M, O'Brien S, Giles F, Koller C, Keating M, Kantarjian H> ;Leuk. Lymphoma. 2000-02-01
• Join now to see all